Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Plos One|September 26, 2018
Humidity as a non-pharmaceutical intervention for influenza AJennifer M Reiman, Biswadeep Das, Gregory M Sindberg, et al.
Frontiers in Neurology|March 3, 2022
Effect of Training on Visual Identification of High Frequency Oscillations-A Delphi-Style InterventionAaron M Spring, Daniel J Pittman, Arsalan Rizwan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast CancerRachel O Abelman, Bogang Wu, Haley Barnes, et al.
Molecular Biology of the Cell|November 24, 2017
Self-oligomerization regulates stability of survival motor neuron protein isoforms by sequestering an SCF<sup>Slmb</sup> degronKelsey M Gray, Kevin A Kaifer, David Baillat, et al.
Cancer Discovery|May 4, 2021
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with PertuzumabOtto Metzger Filho, Giuseppe Viale, Shayna Stein, et al.
Plos One|October 21, 2015
Pangenome Analysis of Burkholderia pseudomallei: Genome Evolution Preserves Gene Order despite High Recombination RatesSenanu M Spring-Pearson, Joshua K Stone, Adina Doyle, et al.
NPJ Breast Cancer|January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.
NPJ Breast Cancer|May 10, 2022
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancerAdrienne G Waks, Neelam V Desai, Tianyu Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2023
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trialL M Spring, S M Tolaney, G Fell, et al.
The Journal of Clinical Investigation|February 1, 2024
HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trialZheqi Li, Otto Metzger Filho, Giuseppe Viale, et al.
Pageof 18